Apollomics (APLM) Long-Term Investments (2022 - 2025)
Apollomics (APLM) posted quarterly Long-Term Investments of $51.3 million for Q4 2025, up 988.1% year-on-year from $4.7 million in Q4 2024, and up 988.1% on a QoQ basis from $4.7 million in Q4 2024.
Apollomics (APLM) Long-Term Investments (2022 - 2025) Analysis & Trends
Apollomics (APLM) has reported Long-Term Investments for 4 consecutive years, with $51.3 million the latest figure, recorded in Q4 2025.
- Quarterly Long-Term Investments rose 988.1% year-over-year to $51.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $51.3 million (up 988.1% YoY) and the FY2025 annual result came in at $51.3 million, up 988.1% from the prior year.
- Long-Term Investments grew to $51.3 million in Q4 2025 per APLM's latest filing, from $4.7 million in the prior quarter.
- Over the last five years, Long-Term Investments for APLM reached as high as $70.6 million in Q4 2022 and fell as low as $4.7 million in Q4 2024.
- A 4-year average of $49.2 million and a median of $60.7 million in 2023 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2024 — Long-Term Investments plunged 93.27% — and 2025, when it surged 988.1%.
- Year by year, Long-Term Investments stood at $70.6 million in 2022, then decreased by 0.65% to $70.1 million in 2023, then tumbled by 93.27% to $4.7 million in 2024, then jumped by 988.1% to $51.3 million in 2025.
- According to Business Quant data, Long-Term Investments over the past three periods registered $51.3 million, $4.7 million, and $70.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - | 51.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51.32 Mn |
| Dec 31, 2024 | 4.72 Mn |
| Dec 31, 2023 | 70.10 Mn |
| Dec 31, 2022 | 70.56 Mn |